Paradigm Biopharmaceuticals Ltd Corporate Call Transcript
Good morning, ladies and gentlemen. My name is Paul Rennie, CEO of Paradigm Biopharmaceuticals Limited. I'd like to welcome you all to Paradigm's investor update to discuss the recent response from the US FDA.
Today's meeting is being held online via the Lumi platform, where attendees can watch a live webcast of the meeting. In addition, shareholders have the ability to ask questions, which will be answered following the presentation. Questions can be submitted at any time throughout the presentation. (Conference Instructions)
Next slide, please. A standard disclaimer applies to this presentation.
Now, from my perspective, I see the situation with the FDA as progressing from six questions down to, now, one question for Paradigm to answer. And we are very confident that we can respond to the FDA within the month. I would now like to hand over to my colleague, Dr. Donna Skerrett, who is Paradigm's Chief Medical Officer, who will take you through a presentation, which will take between 15 and 20 minutes.
After the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |